Agenda

October 25, 2021 ● 1:00 PM – 5:00 PM, EDT
 
1:00 p.m. Welcome
Nora D. Volkow, M.D., Director, National Institute on Drug Abuse (NIDA)

Carlos Blanco M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research, NIDA
 
1:05 p.m. Background

Goal: To promote a basic, common understanding of the key characteristics of coverage for MOUDs as it exists today and the current rates of utilization.

(Each speaker will have 10 minutes, and there will be 10 minutes for clarifying questions)

Moderator:
Barbara “Basia” Andraka-Christou Ph.D., J.D., Assistant Professor, College of Community Innovation and Education, University of Central Florida

Key MOUD-related Coverage Provisions of Federal Legislation (e.g., The Mental Health Parity and Addiction Equity Act, The Affordable Care Act, The Support Act) as Currently Implemented

Medicaid and Medicare - Douglas Olson, M.D., Medical Director, Connecticut Physician Health Program (HAVEN)

Private Coverage - Haiden Huskamp, Ph.D., Henry J. Kaiser Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School

SAMHSA Block Grant and Other Initiatives - Thomas Clarke, Ph.D., M.P.H., Director, National Mental Health and Substance Use Policy Laboratory (NMHSUPL), Substance Abuse and Mental Health Services Administration (SAMHSA)

Latest Findings on Access to and Utilization of MOUDs

Latest Findings from the Medicaid Outcomes Distributed Research Network - Julie Donohue, Ph.D., Professor and Chair, Health Policy and Management, Graduate School of Public Health University of Pittsburgh

Access to Buprenorphine-Prescribing Primary Care Physicians in Medicaid Managed Care - Daniel Polsky, Ph.D., Bloomberg Distinguished Professor, Carey Business School, Health Policy Management, Johns Hopkins Bloomberg School of Public Health

Clarifying Questions and Answers
 
2:05 p.m. Break (10 min)
 
2:15 p.m. Research Needed to Inform Coverage, Benefit Design, Network Determination, Reimbursement, and Reimbursement Rates

Goal: To identify research and evidence gaps related to MOUD coverage, including the following topics:
  • Coverage decisions and benefit design
  • Medical necessity criteria
  • Eligibility for reimbursement
  • Extent and composition of provider networks
  • Reimbursement methods and rates
  • Other MOUD relevant research gaps
(Panel discussion with audience Q&A at the end)

Moderator:
Bradley Stein, M.D., Ph.D., M.P.H., Senior Physician Policy Researcher, RAND

Panelists:
  • Single State Agency Perspective - Sara Goldsby, M.S.W., M.P.H., Director, South Carolina Department of Alcohol and Other Drug Abuse Services
  • State Medicaid Program Perspective - Marcus Bachhuber, M.D., M.P.H., Assistant Professor, L.S.U. School of Medicine; Chief Medical Officer, Louisiana Medicaid Program
  • Private Insurer Perspective – Martin H. Rosenzweig, M.D., Chief Medical Officer, Optum Behavioral Health
  • H.M.O. Perspective – Hayley Y. Park, Pharm.D., M.B.A., Executive Director of Pharmacy, Kaiser Permanent Mid-Atlantic States
3:30 p.m. Break (10 min)
 
3:40 p.m. Examples of Payor/Researcher Partnerships
(Each speaker will have 10 minutes, and there will be 5 minutes for clarifying questions)

Goal: To showcase some successful past partnerships.

Moderator:
A. Thomas McLellan, Ph.D., Founder, Treatment Research Institute

The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study –
Susan Ettner, Ph.D., Dean of Graduate Education, Professor of General Internal Medicine and Health Services Research, David Geffen School of Medicine and Professor, Health Policy and Management, UCLA Fielding School of Public Health

Virginia Addiction Recovery and Treatment Services Program – Lauryn Walker, R.N., M.P.H., Ph.D., Acting Chief Health Economist, Deputy for Health Economics and Economic Policy, Virginia Department of Medical Assistance Services

Clarifying Questions and Answers
 
4:05 p.m. What Resources Are Needed to Move the Field Forward?

Goal: To identify data, methods, potential partnerships, and other resources needed to conduct needed research on coverage for MOUDs.

(Panel discussion with audience Q&A at the end)

Moderator:
Bruce Schackman, Ph.D., M.B.A., Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research; Executive Vice Chair, Department of Population Health Sciences; Director, Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH)

Panelists:
  • Colleen Grogan, Ph.D., Professor, Crown Family School of Social Work, Policy, and Practice University of Chicago
  • Dominic Hodgkin, Ph.D., Professor, The Heller School for Social Policy and Management, Brandeis University
  • Leemore Dafny, Ph.D., Bruce V. Rauner Professor of Business Administration Harvard Business School
  • Jake Morgan, Ph.D., Research Assistant Professor, Department of Health Law, Policy, and Management, Boston University School of Public Health
4:50 p.m. Wrap Up
Carlos Blanco, M.D., Ph.D., Director, Division of Epidemiology, Services and Prevention Research, NIDA
 
5:00 p.m. Adjourn